Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3.

MLA

Chandra, Shruti, et al. “Baseline Characteristics of Eyes with Early Residual Fluid Post Loading Phase of Aflibercept Therapy in Neovascular AMD: PRECISE Study Report 3.” Eye (London, England), vol. 38, no. 7, May 2024, pp. 1301–07. EBSCOhost, https://doi.org/10.1038/s41433-023-02886-1.

APA

Chandra, S., Gurudas, S., Pearce, I., Mckibbin, M., Kotagiri, A., Menon, G., Burton, B. J. L., Talks, J., Grabowska, A., Ghanchi, F., Gale, R., Giani, A., Chong, V., Chen, C. N. T., Nicholson, L., Thottarath, S., Chandak, S., & Sivaprasad, S. (2024). Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3. Eye (London, England), 38(7), 1301–1307. https://doi.org/10.1038/s41433-023-02886-1

Chicago

Chandra, Shruti, Sarega Gurudas, Ian Pearce, Martin Mckibbin, Ajay Kotagiri, Geeta Menon, Benjamin J L Burton, et al. 2024. “Baseline Characteristics of Eyes with Early Residual Fluid Post Loading Phase of Aflibercept Therapy in Neovascular AMD: PRECISE Study Report 3.” Eye (London, England) 38 (7): 1301–7. doi:10.1038/s41433-023-02886-1.